Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ®(Bisphosphonate)¸¦ º¹¿ëÇϴ ȯÀÚ¿¡¼­ ¹ß»ýÇÏ´Â °ñ±«»çÁõ

Bisphosphonate related osteonecrosis of jaw

´ëÇÑÄ¡°úÀÇ»çÇùȸÁö 2011³â 49±Ç 7È£ p.372 ~ 377
Ȳ°æ±Õ,
¼Ò¼Ó »ó¼¼Á¤º¸
Ȳ°æ±Õ ( Hwang Kyung-Gyun ) - ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ Ä¡°úÇб³½Ç ±¸°­¾Ç¾È¸é¿Ü°ú

Abstract


Bisphosphonates are widely used in the management of osteoporosis patients. Many reports and clinical studies have published a relationship between necrotic bone lesions localized to the jaw and the use of chronic bisphosphonate therapy. This osteonecrosis named bisphosphonate-related osteonecrosis of the jaw(BRONJ). This article described the mechanism, chemical structure, indication, risk factor of the bisphosphonate

Å°¿öµå

Bisphosphonate; osteonecrosis; jaw

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI